The first non-ablative fractional skin resurfacing treatment
Designed to create a younger-looking appearance in a single treatment without surgery or injections, Fraxel® delivers outstanding results with minimal downtime.
THE FRAXEL® SYSTEM
The original non-invasive fractional resurfacing treatment that improves tone, texture and radiance of aging, sun-damaged or scarred skin.
FRAXEL® DUAL 1550/1927
Delivery System
Laser with Zimmer Cryo 6 Skin Cooling System
Mode of Action
Non-Ablative
Depth of Penetration
Up to 1.6 mm (1600µm) with 1550 nm wavelength and up to 0.3 mm (300µm) with 1927 nm wavelength
Wavelength
1550 nm and 1927 nm
Energy
Up to 70 mJ (1550 nm) per MTZ and 20 mJ (1927 nm) per MTZ
Handpiece Technology
Intelligent Optical Tracking System (IOTS)
Address both deep and superficial resurfacing
Only system to feature dual fiber laser technology.
Integrated cooling to help aid in patient comfort.
Consistent, even treatment
Patented continuous-motion tracking system delivers consistent treatment.
Simple to use
Intelligent touchscreen interface and precise dosimetry allow physician to easily select the desired treatment settings.
Treatment versatility
Treatment of a variety of conditions on all skin types anywhere on the body.
RESULTS THAT MATTER
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
BEFORE
AFTER
Photos have not been retouched. Individual results may vary.
Fraxel® treats wrinkles, age spots, sun spots, melasma, actinic keratosis, skin resurfacing and scars.
FRAXEL®
The first non-ablative fractional skin resurfacing treatment.
15+
YEARS
Pioneered fractional skin resurfacing in 2003
17+
PATENT APPLICATIONS
One-of-a-kind, non-ablative, fractional technology with more than 17 patent applications filed
50+
CLINICAL STUDIES
Clinically proven for efficacy and results, with over 50 published clinical studies
1M
TREATMENTS
Over 1 million treatments performed and counting
To truly see and hear all that Fraxel® can mean to your practice, you’ll want to talk to one of our practice specialists. We can answer questions about system flexibility, treatment efficacy, patient demand and of course, practice investment.
The Fraxel® 1550, Fraxel® 1927, and Fraxel® DUAL 1550/1927 laser systems are cleared for the following indications for use:
Fraxel® 1550nm wavelength is indicated for dermatological procedures requiring the coagulation of soft tissue; skin resurfacing procedures; treatment of dyschromia and cutaneous lesions, such as, but not limited to lentigos, solar lentigos, actinic keratosis, and melasma; and treatment of periorbital wrinkles, acne scars and surgical scars.
Fraxel® 1927nm wavelength is indicated for dermatological procedures requiring the coagulation of soft tissue; treatment of actinic keratosis; treatment of pigmented lesions, specifically age spots, sun spots and ephiledes.
IMPORTANT SAFETY INFORMATION
The following is a summary of contraindications for Fraxel® 1550, Fraxel® 1927 and Fraxel® DUAL 1550/1927 laser systems treatments. Pre-screening should include, but not be limited to:
Predisposition to keloid formation or excessive scarring;
Pigmentation changes following surgery;
Skin indentations and textural changes following surgery;
Systemic steroids (e.g. prednisone, dexamethasone), which should be rigorously avoided prior to and throughout the course of treatment; and
Patients undergoing isotretinoin acne treatment or with drugs in a similar class.
Do not use Fraxel® 1550, Fraxel® 1927, and Fraxel® DUAL 1550/1927 on any patient who is ineligible for general surgery.
The Fraxel® 1550, Fraxel® 1927 and Fraxel® 1550/1927 DUAL generate a Class 4 laser. Protective eyewear or goggles should be worn by any operator and assistant.
Improper use of Fraxel® may cause personal injury or damage to the system. See the Operator Manual for detailed directions, proper use, and full risk and safety information. For additional product information see www.fraxel.com/hcp.
CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.